Surgery News

Occurrence of thromboembolic events in patients taking edoxaban (Savaysa, Daiichi Sankyo) vs. warfarin after bioprosthetic valve implantation or repair.

Frailty was linked to postprocedural bleeding in older patients undergoing transcatheter aortic valve replacement or surgical AVR, according to a study published in JACC: Cardiovascular Interventions.

A prespecified analysis of the REDUCE-IT trial highlighted a reduction in first and total revascularization events with icosapent ethyl in patients with elevated triglycerides at high CV risk despite statin therapy.

Once the COVID-19 pandemic starts to subside, gradual reintroduction and collaborative approaches are important to continue the care of patients with untreated CVD, according to guidance from 15 North American cardiology societies.

Abiomed announced it has acquired Breethe, developer of an extracorporeal membrane oxygenation system, in an effort to better support patients with cardiogenic shock or other conditions which produce insufficient oxygen to the lungs.

The use of radial artery grafts for CABG was linked to lower risk for CV outcomes and improved survival compared with the use of saphenous vein grafts, according to 10-year follow-up data from the Radial Artery Database International Alliance presented at the American College of Cardiology Scientific Session.

CytoSorbents Corp. announced that its blood purification technology for the treatment of deadly inflammation and cytokine storm has been granted Emergency Use Authorization by the FDA for patients with COVID-19.

Myocardial flow reserve from PET imaging in patients with ischemic HF may identify those with a greater outcome benefit from CABG vs. PCI, according to data presented at the American College of Cardiology Scientific Session.

Patients with severely reduced left ventricular ejection fraction and CAD who underwent PCI had higher rates of MACE and mortality compared with those who underwent CABG, according to a study published in JAMA Cardiology.

Among modifiable risk factors, anemia, as measured by preoperative hematocrit level, contributed the most to mortality risk in patients with HF undergoing noncardiac surgery, according to a research letter published in JAMA Surgery.